]>
IRCT20221008056114N1 IRCT 2022-11-22 Qazvin University of Medical Sciences Comparison of diagnostic accuracy of endometrial curettage and aspiration biopsy in patients with endometrial hyperplasia Comparison of diagnostic accuracy of endometrial curettage and aspiration biopsy in patients with endometrial hyperplasia treated with progesterone 2022-12-06 anticipated 84 Complete https://irct.ir/trial/66218 interventional Randomization: N/A, Blinding: Single blinded, Placebo: Not used, Assignment: Single, Purpose: Diagnostic, Blinding description: This study is one-sided blind. The samples are only sent to a specific pathologist, and in order for the pathologist not to know the type of sample, the samples are sent to pathology under the title endometrial sample 1 (for papillitis) and endometrial sample 2 (for dilatation and curettage) and their results are compared. will be. 3 Endometrial hyperplasia. Intervention group: Medroxyprogesterone tablets 20 mg daily for 15 days to 3 months are placed (with any treatment regimen). After 4 weeks of treatment, endometrial samples will be taken from each patient through 2 methods, Pipell followed by D&C.. Yes - There is a plan to make this available What will be shared: The collected information is in the form of a questionnaire and is statistically analyzed. When: The start of the access period is one year after the results are published. To whom: For obstetricians and researchers working in academic institutions Conditions: Evaluate the path and process of study and analyze it Where to obtain: For information, refer to Dr. Bahar Gholamnia. The communication channels are as follows: By sending an email to the address: bahar.gholamnia@ymail.com or referring and contacting Kosar Hospital at the address: Qazvin, Taleghani St. Phone: 028-33236374 Postal address: 34156-13176 How to obtain: After sending the e-mail, the requested information will be reviewed by the facilitator and the person responsible for the scientific responsibility of the study. At your discretion, the requested information will be sent within 10 days of receiving the email. Comments:
public Bahar Gholamnia
Bahonar Blvd, Qazvin
Qazvin Iran (Islamic Republic of) 3413786313 +98 28 3333 6001 bahar.gholamnia@ymail.com Qazvin University of Medical Sciences scientific Dr Masoumeh Dadashaliha
Kosar Hospital, Taleghani St., Qazvin
Qazvin Iran (Islamic Republic of) 13176- 34156 +98 28 3323 6374 dadashaliham@yahoo.com Qazvin University of Medical Sciences Iran (Islamic Republic of) Age 18 to 47 years Diagnosis of uterine hyperplasia with AUB Absence of focal lesion 18 years 47 years Female The patient's unwillingness to participate in the study Improper use of medication Presence of focal endometrial lesion Patient willingness to hysterectomy N85.0 Endometrial hyperplasia Diagnosis Intervention group: Medroxyprogesterone tablets 20 mg daily for 15 days to 3 months are placed (with any treatment regimen). After 4 weeks of treatment, endometrial samples will be taken from each patient through 2 methods, Pipell followed by D&C. Uterine hyperplasia. Timepoint: Before treatment. Method of measurement: Curtage. Endometrial hyperplasia. Timepoint: Three months after treatment. Method of measurement: Sampling of the endometrium and comparison of pathologies. Qazvin University of Medical Sciences Approved 2021-11-16 Ethics Committee of Qazvin University of Medical Sciences Vice chancellor for research, Qazvin University of Medical Sciences, Shahid Bahonar blvd Qazvin Qazvin Iran (Islamic Republic of)